| Exosome Processing and Characterization Approaches for Research and Technology Development JJ Lai, ZL Chau, SY Chen, JJ Hill, KV Korpany, NW Liang, LH Lin, YH Lin, ... Advanced Science, 2103222, 2022 | 143 | 2022 |
| Treatment and renal outcomes up to 96 weeks after tenofovir alafenamide switch from tenofovir disoproxil fumarate in routine practice H Toyoda, J Leong, C Landis, M Atsukawa, T Watanabe, DQ Huang, J Liu, ... Hepatology 74 (2), 656-666, 2021 | 39 | 2021 |
| Renal outcomes with tenofovir alafenamide in liver transplant recipients JK Liu, P Vutien, DQ Huang, M Ishigami, C Landis, MH Nguyen, ... Clinical Gastroenterology and Hepatology, 2022 | 3 | 2022 |
| RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR J Liu, P Vutien, D Huang, M Ishigami, PCYN Daniel, T Ito, H Dang, ... HEPATOLOGY 74, 492A-493A, 2021 | | 2021 |
| VIROLOGIC, BIOCHEMICAL, AND RENAL OUTCOMES OF TREATMENT-NAÏVE PATIENTS WITH SEQUENTIAL THERAPY FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN … H Toyoda, HN Trinh, J Leong, M Atsukawa, T Watanabe, M Chuma, J Liu, ... The Liver Meeting Digital Experience™, 2020 | | 2020 |
